Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities Report
Queensland Bauxite Limited (ASX:QBL) provides the Company's Quarterly Activities Report.
Queensland Bauxite Limited (ASX:QBL) provides the Company's Quarterly Activities Report.
Nanollose Limited (ASX:NC6) is pleased to provide its Appendix 4C Cashflow Statement for the quarter ended 31 December 2017, together with the following operational update.
Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.
Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $1,230,329 from the Australian Taxation Office under the Federal Government's Research and Development Tax Incentive scheme.
I am delighted and proud on behalf of the Board of Queensland Bauxite Limited (ASX:QBL) to inform our shareholders that Mr John Easterling has agreed to join the board of our Cannabis subsidiary Medical Cannabis Limited.
The Board of Queensland Bauxite Ltd (ASX:QBL) is thrilled to be involved in bringing to Australia, through its subsidiary MCL, a fundamentally new product in the world cannabis market, and especially in the Australian market that should be one that will be accepted by the medical industry at large due to the unique benefits and advantages enumerated below.
The Board of Queensland Bauxite (ASX:QBL) is pleased to update its shareholders about the significant progress that its subsidiary company Medical Cannabis Limited (MCL) has recently made in executing its business plan and particularly in relation to MCL's Vitahemp food company and its impressive client list.